Summit Therapeutics Inc Forecast and Target Price

Currently 7 wall-street analysts regularly analyze the financials of Summit Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 7 analysts offering 12-month price forecasts for Summit Therapeutics Inc (SMMT) have a share price target of $32.32. This median of share price forecast represents a 89.65% upside from the latest price of $17.04 as on 20.12.25.

Below is a chart showing the percentage difference between Summit Therapeutics Inc's share price and its median forecast price. As on 20.12.25, the difference is -46.59%